Ironwood Pharmaceuticals Inc (IRWD)-Financial and Strategic SWOT Analysis Review

Ironwood Pharmaceuticals Inc (IRWD)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH130084FSA
  • |
  • Pages: 59
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Ironwood Pharmaceuticals Inc (IRWD)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ironwood Pharmaceuticals Inc (Ironwood), is a commercial biotechnology company that discovers, develops and commercializes medicines for gastrointestinal (GI) disorders. The company's marketed product portfolio consists of Linzess (linaclotide), an oral capsule indicated for the treatment of irritable bowel syndrome with constipation or chronic idiopathic constipation in adult men and women; and Zurampic (lesinurad), for the treatment of hyperuricemia associated with gout in patients. Ironwood also evaluates linaclotide in other indications, new formulations and in combination with other products for developing therapeuticstreatments in various GI conditions. Its pipeline product portfolio comprises Duzallo (lesinurad and allopurinol), a fixed-dose combination product for the treatment of hyperuricemia in patients with uncontrolled gout; and other development programs targeting vascular and fibrotic diseases. Ironwood is headquartered in Cambridge, Massachusetts, the US.

Ironwood Pharmaceuticals Inc Key Recent Developments

Feb 21, 2017: Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update

Jan 08, 2017: Ironwood Pharmaceuticals Demonstrates Strong Execution on Strategy to Build Top-Performing Commercial Biotech

Jan 04, 2017: Ironwood Pharmaceuticals Appoints Amy Schulman to Board of Directors

Nov 03, 2016: Ironwood Pharmaceuticals Provides Third Quarter 2016 Investor Update

Aug 04, 2016: Ironwood Pharmaceuticals Provides Second Quarter 2016 Investor Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Ironwood Pharmaceuticals Inc-Key Facts 6

Ironwood Pharmaceuticals Inc-Key Employees 7

Ironwood Pharmaceuticals Inc-Key Employee Biographies 8

Ironwood Pharmaceuticals Inc-Major Products and Services 9

Ironwood Pharmaceuticals Inc-Pharmaceutical Pipeline Products Data 10

Ironwood Pharmaceuticals Inc, Pipeline Products by Therapy Area 10

Ironwood Pharmaceuticals Inc, Pipeline Products by Development Phase 11

Ironwood Pharmaceuticals Inc-History 12

Ironwood Pharmaceuticals Inc-Company Statement 15

Ironwood Pharmaceuticals Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 18

Ironwood Pharmaceuticals Inc-Business Description 18

Ironwood Pharmaceuticals Inc-Corporate Strategy 19

Ironwood Pharmaceuticals Inc-SWOT Analysis 20

SWOT Analysis-Overview 20

Ironwood Pharmaceuticals Inc-Strengths 20

Ironwood Pharmaceuticals Inc-Weaknesses 21

Ironwood Pharmaceuticals Inc-Opportunities 22

Ironwood Pharmaceuticals Inc-Threats 23

Ironwood Pharmaceuticals Inc-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Ironwood Pharmaceuticals Inc, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Feb 21, 2017: Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update 34

Jan 08, 2017: Ironwood Pharmaceuticals Demonstrates Strong Execution on Strategy to Build Top-Performing Commercial Biotech 38

Jan 04, 2017: Ironwood Pharmaceuticals Appoints Amy Schulman to Board of Directors 39

Nov 03, 2016: Ironwood Pharmaceuticals Provides Third Quarter 2016 Investor Update 40

Aug 04, 2016: Ironwood Pharmaceuticals Provides Second Quarter 2016 Investor Update 43

May 09, 2016: Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update 47

Apr 07, 2016: Ironwood Pharmaceuticals Appoints Andrew Dreyfus to Board of Directors 50

Mar 30, 2016: Ironwood Pharmaceuticals to Present Clinical and Preclinical Data on sGC Stimulators at Upcoming Scientific Conferences 51

Feb 18, 2016: Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2015 Investor Update 52

Section 6-Appendix 55

Methodology 55

Ratio Definitions 55

About GlobalData 59

Contact Us 59

Disclaimer 59

List of Figures

Ironwood Pharmaceuticals Inc, Pipeline Products by Therapy Area 10

Ironwood Pharmaceuticals Inc, Pipeline Products by Development Phase 11

Ironwood Pharmaceuticals Inc, Performance Chart (2011-2015) 28

Ironwood Pharmaceuticals Inc, Ratio Charts 30

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 32

List of Tables

Ironwood Pharmaceuticals Inc, Key Facts 6

Ironwood Pharmaceuticals Inc, Key Employees 7

Ironwood Pharmaceuticals Inc, Key Employee Biographies 8

Ironwood Pharmaceuticals Inc, Major Products and Services 9

Ironwood Pharmaceuticals Inc, Number of Pipeline Products by Therapy Area 10

Ironwood Pharmaceuticals Inc, Number of Pipeline Products by Development Stage 11

Ironwood Pharmaceuticals Inc, History 12

Ironwood Pharmaceuticals Inc, Subsidiaries 17

Ironwood Pharmaceuticals Inc, Key Competitors 24

Ironwood Pharmaceuticals Inc, Ratios based on current share price 25

Ironwood Pharmaceuticals Inc, Annual Ratios 26

Ironwood Pharmaceuticals Inc (Cont...1), Annual Ratios 27

Ironwood Pharmaceuticals Inc, Interim Ratios 29

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Ironwood Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Ironwood Pharmaceuticals Inc, Recent Deals Summary 33

Currency Codes 55

Capital Market Ratios 55

Equity Ratios 56

Profitability Ratios 56

Cost Ratios 57

Liquidity Ratios 57

Leverage Ratios 57

Efficiency Ratios 58

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Horizon Pharma Plc, Arena Pharmaceuticals Inc, AMAG Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Alkermes Plc, Acorda Therapeutics Inc

Ironwood Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 7966
Site License
USD 250 INR 15933
Corporate User License
USD 375 INR 23899

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com